Gilead to Acquire German Cancer Biotech Tubulis for Up to $5 Billion
Gilead Sciences announced plans to acquire German cancer drug developer Tubulis for up to $5 billion to strengthen its oncology pipeline.
Gilead Sciences announced plans to acquire German cancer drug developer Tubulis for up to $5 billion to strengthen its oncology pipeline.

A surgeon's medical malpractice case has resulted in nearly £20 million in NHS compensation payments to over 450 injured patients.

Jose Medina, accused of fatally shooting a Chicago college student, was hospitalized for tuberculosis treatment and missed his first court appearance.

Anthem Blue Cross Blue Shield changed its coverage policy for pediatric brain surgery after NBC News inquired about a denied claim for a 13-year-old with daily seizures.

A Chicago police officer was fatally shot and another critically wounded by a robbery suspect receiving medical treatment while in police custody at a hospital.

Health Secretary Robert F. Kennedy Jr. is challenging major coffee chains about sugar content in drinks while polling shows declining trust in health agencies.

Several pharmaceutical stories emerged involving cancer treatment trials, FDA peptide regulations, obesity drug coverage changes, and potential industry deals.

Nine people, including children, have been sickened in an E. coli outbreak connected to raw milk and cheese from a California company.

Researchers report advances in diagnostic tools for tuberculosis and endometriosis that could improve accuracy and reduce diagnosis times.

FBI arrests eight people in $60 million healthcare fraud scheme as task force suspends 221 hospice and healthcare providers in California.

Federal and state health officials have issued separate food safety alerts involving listeria-contaminated soft cheese and salmonella concerns in alfredo sauce.

Scientists have identified a previously unknown bacterial species in patients with noma, a fatal disease that destroys facial tissues in children.

New clinical trial finds baduanjin, a traditional Chinese exercise, could reduce blood pressure as effectively as some medications.

About 50 health insurance companies committed Friday to accelerating reforms aimed at reducing administrative burdens in prior authorization processes.

Canadian regulators have approved the country's first generic version of the popular diabetes medication Ozempic.
Page 17 of 42 (620 stories)